statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	603
RU - Federazione Russa	216
IT - Italia	119
SG - Singapore	116
CN - Cina	103
IE - Irlanda	72
GB - Regno Unito	67
DE - Germania	42
BR - Brasile	40
FR - Francia	36
HK - Hong Kong	33
SE - Svezia	26
IN - India	24
KR - Corea	22
FI - Finlandia	21
VN - Vietnam	17
ES - Italia	10
NL - Olanda	10
UA - Ucraina	10
PL - Polonia	9
JP - Giappone	8
MX - Messico	8
RS - Serbia	8
CA - Canada	6
IQ - Iraq	6
BD - Bangladesh	4
CZ - Repubblica Ceca	4
PK - Pakistan	4
VE - Venezuela	4
ZA - Sudafrica	4
CH - Svizzera	3
EG - Egitto	3
GR - Grecia	3
IR - Iran	3
PY - Paraguay	3
AR - Argentina	2
AT - Austria	2
LK - Sri Lanka	2
MY - Malesia	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AZ - Azerbaigian	1
BE - Belgio	1
BG - Bulgaria	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CY - Cipro	1
GT - Guatemala	1
HU - Ungheria	1
JM - Giamaica	1
KE - Kenya	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MA - Marocco	1
NO - Norvegia	1
PE - Perù	1
PT - Portogallo	1
SA - Arabia Saudita	1
SC - Seychelles	1
UG - Uganda	1
UZ - Uzbekistan	1
Totale	1.698

Nome	#
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients	232
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype?	231
Non-neoplastic asbestos-related respiratory diseases: what relationship with other lung diseases?	189
Biomarkers in COVID-19 pandemic: implications for acute phase assessment and chronic management	182
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19	175
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female	175
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis	173
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases	151
Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae	110
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis	69
Biomarkers of Sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme and KL-6	47
Totale	1.734

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	47	0	0	0	0	0	8	4	15	3	7	4	6
2021/2022	80	1	8	7	2	3	1	7	6	5	12	13	15
2022/2023	143	6	19	20	24	7	24	8	15	11	6	0	3
2023/2024	193	9	1	8	8	6	39	38	8	11	25	8	32
2024/2025	463	28	28	49	26	47	31	49	26	32	29	37	81
2025/2026	622	66	118	103	138	191	6	0	0	0	0	0	0
Totale													1.734